Lords Mark Biotech has achieved a significant global milestone by securing World Health Organization (WHO) prequalification for its HIV diagnostic kits, joining an elite group of just nine companies worldwide. This recognition underscores the company's commitment to quality and innovation in healthcare diagnostics.
Breakthrough in HIV Testing
The WHO prequalification ensures that Lords Mark's diagnostic kits meet rigorous international standards for accuracy, reliability, and safety. This achievement is expected to enhance access to high-quality HIV testing, particularly in low- and middle-income countries where the burden of the disease is highest.
Impact on Global Health
With this certification, Lords Mark can now supply its HIV diagnostic kits to United Nations agencies and other global health organizations. The company's products will play a crucial role in the fight against HIV/AIDS, aiding early detection and treatment monitoring.
India's contribution to global health diagnostics has been steadily growing, and this achievement places Lords Mark among a select few global players. The company plans to scale up production to meet international demand, further strengthening India's position in the medical technology sector.
Company's Vision
Lords Mark aims to expand its portfolio of diagnostic solutions, leveraging this recognition to enter new markets and collaborate with global health partners. The company's CEO stated, "This milestone reflects our dedication to saving lives through accessible and affordable diagnostics."
The WHO prequalification is a testament to the company's adherence to stringent quality standards and its ability to deliver reliable products. It also opens doors for future innovations in infectious disease diagnostics.
